Plain-English translation of NCT03276923 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study—meaning researchers collect and track medical information from women with autoimmune diseases during pregnancy and after delivery. You would not receive any experimental medications or undergo tests outside of your normal doctor visits. Instead, researchers will use your existing medical records and routine care information to learn how autoimmune diseases affect pregnancy and what outcomes mothers and babies experience.
Women with autoimmune diseases face unique challenges during pregnancy, but we don't have enough detailed information about how these conditions and their treatments affect both mother and baby. This registry aims to gather that information so doctors can better support pregnant women with autoimmune diseases in the future.
You likely qualify if…
You likely don't qualify if…
You would continue seeing your regular rheumatologist and obstetrician as you normally would—no extra appointments or tests are required. Researchers will collect information from your office visits during pregnancy and for up to 12 months after your baby is born, recording how your autoimmune disease is managed and how your pregnancy progresses. Your participation helps build a database that researchers can study over time to improve care for pregnant women with autoimmune diseases.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Sponsor
Duke University
Enrollment target
~1,000 participants
Started
January 2018
Primary completion
January 2027
Sex
Female only
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Laura Neil
Duke Health
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.